GenSight Biologics: Stable Euro Stock, Low Volatility, Low Valuation in Neurodegenerative Research
GenSight Biologics: low‑volatility biotech shares, €0.08 close, stable 52‑week range, focused on mitochondrial and neurodegenerative eye therapies.
2 minutes to read